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Abstract
Background: Adequate performance assessment benefits from the use of disaggregated data to allow a proper
evaluation of health systems. Since routinely collected data are usually not disaggregated enough to allow stratified
analyses of healthcare needs, utilisation, cost and quality across different sectors, international research projects
could fill this gap by exploring means to data collection or even providing individual-level data. The aim of this
paper is therefore to (1) study the availability and accessibility of relevant European-funded health projects, and (2)
to analyse their contents and methodologies.
Methods: The European Commission Public Health Projects Database and CORDIS were searched for eligible
projects, which were then analysed by information openly available online.
Results: Overall, only a few of the 39 identified projects produced data useful for proper performance assessment,
due to, for example, lacking available or accessible data, or poor linkage of health status to costs and patient
experiences. Other problems were insufficient databases to identify projects and poor communication of project
contents and results.
Conclusions: A new approach is necessary to improve accessibility to and coverage of data on outcomes, quality
and costs of health systems enabling decision-makers and health professionals to properly assess performance.
Keywords: Health system performance assessment, EU healthcare projects, Individual-level data, Data accessibility
Background
Adequate health system performance information is re-
quired to assess whether health systems offer high-
performing health services to their populations, and
therefore to carry out actions to improve them [1]. The
necessary information could be collected and analysed at
the national level; however, more important conclusions
can be drawn through international comparisons, ideally,
if individual-level data for different diseases, interventions
and providers is available to take account of variations in
population groups, such as health status, income and
educational level, and service delivery. Thus, a better
understanding of how processes may lead to various
outcomes can be achieved compared to aggregated data
that only offers average values. Users of the information
generated by individual-level data are not only health
service researchers but all those who are interested in
health systems – such as epidemiologists, economists,
policy advisors or funders of research. While individual
expectations might differ, they optimally all expect to
find (access to) data, which are individual level, longitu-
dinal and detailed enough to allow a stratified analysis
of healthcare needs, healthcare utilisations, costs and
quality across different sectors and performance areas* Correspondence: britta.zander@tu-berlin.de
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of the healthcare system, not only within individual
countries, but across different countries.
However, disaggregated data are often still not routinely
collected, analysed, reported and/or made available for re-
search due to several privacy and data protection issues. Re-
search projects could be theoretically used to fill this gap,
either by exploring how individual-level data can be col-
lected and usefully analysed or even by regularly providing
such data, both within and especially across countries. In
order to facilitate the search of such health information, sev-
eral EU health information systems were initiated, including
CORDIS (the Community Research and Development In-
formation Service for Science, Research and Development,
http://cordis.europa.eu/projects/home_en.html), the Health-
EU portal (http://ec.europa.eu/health/index_en.htm),
EUPHIX (EU Public Health Information & Knowledge
System, http://www.euphix.org/) or DG SANCO’s HEIDI
wiki (Health in Europe: Information and Data Interface)
(https://webgate.ec.europa.eu/sanco/heidi/index.php/
Main_Page). In reality, however, it has often remained
a challenge to maintain an overview of all data pro-
duced (let alone to access them). The Health Research for
Europe project, which aimed to synthesise results of
health research from the EU’s Fifth and Sixth Framework
Programmes (FP5 and FP6), criticised CORDIS for its in-
sufficient data collection and compared the platform with
the concept of a black hole, since “the results of projects
seem to disappear” [2] when searching for EU-funded re-
search [3]. EUPHIX also seems to be inadequate, since it
had to be taken off-line due to discontinuity of funding.
The unavailability of adequate information thus ham-
pers the evidence base to improve performance [3]. Fur-
thermore, a lot of research reported in conference
abstracts has never been published as full reports [4] –
and to be more accurate, more than 50% of the 3691
health-related research projects funded in FP5 and FP6
did not produce any academic output that could be traced
through PubMed or Google scholar [5]. Furthermore, suf-
ficient strategies adopted by researchers to inform policy-
makers on their results are scarce [6]. Nevertheless, since
Horizon 2020, much has moved in the right direction as
the Commission recognised their need to address those
imperfections [7]; however, it still remains to be asked:
How much is really known about EU-funded research
projects and their results?
The compartmentalisation of health data initiatives on
the one hand and poor integration between EU Research
Programmes and national programmes on the other, re-
sult in uncoordinated health research activities between
member states [8]. To overcome this challenge, the FP7-
project EuroREACH (A Handbook to Access Health
Care Data for Cross-Country Comparisons of Efficiency
and Quality) was initiated to contribute to a more sys-
tematic performance assessment of health systems by
enabling access to and use of international and national
health information systems and EU research projects.
An online platform, the Health Data Navigator
(www.healthdatanavigator.eu), was developed to share
the output of the project online. The present article has
derived from work done in one of EuroREACH’s work
packages, namely WP2, which investigated international
and EU health projects with the aim to improve
consistency and comparability of healthcare data. Since
previous research suggested to place more emphasis on
the output of EU projects rather than on the inputs, we
approached it yet from a different perspective with an
attempt to understand and categorise the output of EU
health projects in order to provide a potential user of
comparative healthcare information with a data inven-
tory to address a hypothesised research need. Thus, the
following questions guide our analysis:
1. What kind of health information are we able to find
with respect to the availability and accessibility of
relevant output from EU-projects?
2. Are we able to identify any pattern in the distribution
of research funding towards certain performance
domains, care settings, disease groups or scope of
research?
Methods
We concentrated our search on EU health research pro-
jects and initiatives. Therefore, a systematic search using
relevant search terms was conducted in CORDIS as well
as in the European Commission Public Health Projects
Database (http://ec.europa.eu/health/projects/index_en.htm).
The systematic search was done in two rounds of screening
in each of the databases. The search in the European Com-
mission Public Health Projects Database was filtered through
the following selectable terms: ‘major and chronic disease’,
‘mental health’, ‘health indicators’, and ‘data collection’, and by
year. Projects conducted between 2000 and 2003 were
searched in the archive database (http://ec.europa.eu/health/
ph_projects/project_previous_en.htm), filtered by ‘health
monitoring’ and ‘cancer’, since the abovementioned terms
were not selectable therein. In CORDIS, the search was fil-
tered by framework programs (5th, 6th, 7th), and refined
through the generic subjects ‘medicine and health’ and
‘healthcare delivery/services’. Since the CORDIS database
search does not allow the option of filtering projects by topic
(e.g. by disease), the search in each framework was done by
entering following keywords into the search bar: ‘asthma’, ‘car-
diovascular diseases’, ‘diabetes’, ‘cancer’, ‘chronic obstructive
pulmonary disease’, ‘chronic disease’, ‘mental health’, ‘equity’
and ‘quality’.
In total, 63 projects (18 in European Commission Pub-
lic Health Projects Database and 45 in CORDIS) were
identified on project title review and information based
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on the following inclusion criteria, as agreed by the
EuroREACH consortium, (1) conducted between 2000
and 2012 (ongoing projects which started before 2000
were included); (2) comparative across countries (i.e. at
least two countries involved); (3) using individual-level
data (the one exception made to this rule was to include
population-based cancer registry data); (4) addressing
asthma, cancer, cardiovascular disease (CVD), diabetes,
mental health; or (5) projects with no clear disease focus,
but studying matters of access, efficiency, quality and/or
equity in healthcare. The projects included in the first
step were then retrieved and individually screened to fil-
ter out projects not directly relevant due to no actual
use of individual-level data, inappropriate study design,
or simply due to lacking information. As a result of the
second screening, 34 studies were included in the analysis.
A further five studies were included after conversations
with public health experts (COMPARE, EPSILON, GBD,
Monica, and the OECD Study; see Table 1 for full names).
Our final analysis therefore included 39 projects.
Results
The selection of final projects and inherent websites is
displayed in Table 1. To capture the distribution of all
projects and their distribution across associated partner
countries, an overview of participation levels is provided
in Additional file 1. Accordingly, Germany, Spain, France,
Italy, Netherlands, and the United Kingdom were the
EU countries participating in most projects (at least in
28), compared to e.g. Cyprus, Czech Republic, Latvia,
Luxembourg and Slovakia, which participated in the
least (maximum of 8). These results are supported by
previous research by Galsworthy and McKee [7], who
found that the original 15 member states had received
34 times more health research funding under FP7 than
the 12 (now 13) newest members.
A comprehensive overview on essential project informa-
tion such as ‘governance’, ‘output and results’, or ‘access to
data’ can be found on the initially mentioned Health Data
Navigator by clicking on the respective project.
In respect to research question 1, Fig. 1 indicates the
distribution of EU projects across performance domains.
In order to systematically analyse the project information
and indicate data gaps, all projects were firstly mapped
onto the appropriate health system performance domains,
and additionally subdivided by care sector, disease field
and targeted population group (Fig. 1). The performance
domains refer to the OECD Health Care Quality Indica-
tors Framework, a methodological health system perform-
ance assessment framework, which was modified to meet
the needs of the EuroREACH project of highlighting the
production process [9]. Furthermore, to obtain a compre-
hensive overview on their distribution, all projects were
distinguished by whether they target whole populations,
i.e. including healthy individuals, or only patients, i.e.
diseased individuals. For the latter, we further divided
projects by whether they were cross-sectional or not. The
disease field dimension was also incorporated into the
figure by highlighting projects in different colours (disease
fields and corresponding colours are presented in the key
below Fig. 1).
Population-based projects
Projects targeting whole populations are unevenly distrib-
uted across performance domains (Fig. 1). The majority of
projects only cover the domains ‘health status’ and ‘non-
healthcare determinants of health’, with a few exceptions
also looking at ‘healthcare system performance’, ‘health sys-
tem design and context’ and ‘equity’. This might, however,
be due to the fact that population-based projects rather
assess and compare health statuses by, for example, ana-
lysing different lifestyles, intervention starting points, etc.
to investigate risk factors for certain conditions (e.g. EPIC)
or their impact on population health (e.g. GBD), as well as
address healthy ageing (e.g. SHARE) and/or tackle in-
equality (EuroTHINE), than targeting health services or
their performance. In respect to the disease fields covered,
most of the population-based projects can be mapped to
non-disease specific projects.
Patient-based projects
Patient-based projects show a better balanced distribution
across performance domains, including areas such as
quality, efficiency or access to healthcare. We identified
projects (e.g. EUNICE) covering all performance domains,
whereas others (e.g. RARECARE) cover only one. Among
the specific healthcare performance domains, quality was
researched most, and efficiency least.
Most projects addressed the hospital and primary care
sector and were mapped to the category ‘across sectors’,
seven projects were mapped to the inpatient sector
(which often benchmark hospital performance, study the
quality of the care process and/or different treatment
methods) and two projects to the outpatient sector. Thus,
the number of projects addressing primary care was con-
siderably smaller than the number of projects addressing
the hospital sector, which most likely is not limited to just
our project sample.
Disease fields most frequently covered are cancer and
CVD. Mental health projects are clearly underrepresented,
as well as asthma and diabetes, which might partly be due
to the only few primary care projects included. Hospital-
based projects mostly study cancer and CVD as well as
various acute diseases and focus less on diabetes, asthma
and mental health, whereas the primary care projects in
our sample rather assess and compare primary care sys-
tems than specific diseases.
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Table 1 List of projects and associated websites
Project Website (as of December 2016)
B.I.R.O. (started in 2005)
(Building a Shared European Diabetes Information System)
www.biro-project.eu/home.htm
COMPARE (initiated in 2006) No project website available
De-Plan (2005–2008)









(European Community Health Indicators and Monitoring)
www.ec.europa.eu/health/indicators/indicators/index_en.htm
ECHO (2010–2013)
(European Collaboration for Health Optimization Project)
www.echo-health.eu/?site
ECRHS III (ongoing project initiated in 2010)
(European Community Respiratory Health Survey III)
www.ecrhs.org/ECRHSIII.htm
EPIC (initiated in 1992)
(European Prospective Investigation into Cancer and Nutrition)
http://epic.iarc.fr/
EPIC-CVD (2012–2015)
(Individualized CVD risk assessment across Europe)
www.epiccvd.eu/
EPIC-Elderly (2002–2005)
(The role of diet on the longevity of elderly Europeans)
http://epic.iarc.fr/research/healthyagingepicelderly.php
EPSILON (1996–2000)
(A study of care for people with schizophrenia in five European
centres)
No project website available
EROS (2002–2005)
(The use of stroke registers to assess the quality of stroke
management across Europe)
No project website available
ESAW (2002–2004)
(European Study of Adult Well-Being)
No official project website available, only a German one:
http://www.univie.ac.at/ESAW/
EUBIROD (started in 2008)




(European Network for Indicators on Cancer)
No project website available
EUPHORIC (2004–2008)
(EU Public Health Outcome Research and Indicators Collection)
No project website available
EUPrimeCare (2010–2012)
(Quality and Cost of Primary Care in Europe)
www.eski.hu/new3/kutatas_en/Euprimecare_en.php
EurHOBOP (2009–2011)
(European Hospital Benchmarking by Outcomes in Acute
Coronary Syndrome Processes)
No project website available
EuroCARE Project (1978–2007)
(European Cancer Registry-based study)
www.eurocare.it/
EUROCHIP-3 (2008–2011)
(European Cancer Health Indicator Project)
www.tumori.net/eurochip/
EUROCISS (2000–2007)
(European Cardiovascular Indicators Surveillance Set)
www.cuore.iss.it/eurociss/en/project/project.asp
EuroDRG (2009–2011)




(European Health Care Outcomes, Performance and Efficiency)
www.eurohope.info/
EuroTHINE (2004–2007)
(Tackling Health Inequalities in Europe)
www.irdes.fr/EspaceAnglais/International/Eurothine.html
Ga2LEN (2004–2009) www.ga2len.net/
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In respect to research question 2, to find out what the
projects can tell us about their data and whether there
are research imbalances detectable, each project was sys-
tematically analysed for details on project objectives,
coverage and methods used (Fig. 2). Accordingly, cat-
egories for both project objectives and methods were
built and populated. The number of projects included in
Fig. 2 deviated from those in Fig. 1, since for seven pro-
jects the information given on the websites was not suf-
ficient to adequately complete the table.
Regarding project objectives (x-axis), most projects
address disease monitoring, healthy ageing, hospital
performance and quality of treatment. Data on patient
experiences was lacking in most countries, though patient
feedback is essential for improving healthcare provision.
Information on healthcare costs and health expenditure
for particular services and goods is also very poor in these
projects, hampering the understanding of health system
performance and efficiency. This, however, is often due to
the fact that data on costs by diseases and different
socioeconomic groups are particularly difficult to obtain
for research purposes in many countries.
Thus, two main types of projects exist in the study
sample, namely (1) those that monitor health, risk fac-
tors or particular diseases across whole populations and
develop or adapt indicators but which do not allow an
assessment of health system performance (as these dimen-
sions are not included) and (2) those that are often con-
fined to hospital performance, which are patient-level, but
necessarily leave out healthy individuals. Fewer projects
address equity, patients’ needs and satisfaction or assessed
primary care models.
With respect to methods (y-axis), most of the projects
in our sample used survey data, administrative patient-
level data (i.e. hospital discharge, medical records) and
registries. Fewer projects used biomarkers and/or results
of a clinical examination (e.g. waist circumference), ag-
gregated statistical data, interviews or focus groups and
vignettes. Projects designed for the hospital sector most
commonly used patient outcome data, some of which
Table 1 List of projects and associated websites (Continued)
(Global Allergy and Asthma European Network)
GBD (2007–2010)
(Global Burden of Diseases, Injuries, and Risk Factors Study)
www.healthmetricsandevaluation.org/GBD
HAEMACARE (2005–2008)
(Cancer Registry Based project on Haematologic malignancies)
www.haemacare.eu
Project website not accessible
HALE (2001–2004)
(Healthy Ageing: a Longitudinal study in Europe)
No project website available. Final report available on: www.rivm.
nl/bibliotheek/rapporten/260853003.pdf
I2SARE (1999–2007)
(Health indicators in the European regions)
www.isare.org/
ISAAC (initiated in 1991)
(International Study of Asthma and Allergies in Childhood)
www.isaac.auckland.ac.nz/index.html
JA EHLEIS (2011–2014)
(Advanced research on European health expectancies)
www.eurohex.eu/index.php?option=welcome
Monica (initiated in the early 1980s)
(Multinational MONItoring of Trends and Determinants in
CArdiovascular Disease)
www.thl.fi/monica/
OECD Study (initiated in 2003)
(of Cross-National Differences in the Treatment, Costs and
Outcomes of Ischaemic Heart Disease)




(Pooling of European Data to Harmonize Translational
Research in Breast Cancer)
No project website available
PDCAAE (2000–2003)
(Prevalence and determinants of childhood asthma and
allergies across Europe)
No project website available
QUALICOPC (2010–2013)
(Evaluating primary care in Europe)
www.nivel.nl/en/qualicopc
RARECARE (2007–2010)
(Surveillance of rare cancers in Europe)
www.rarecare.eu/
SHARE project (initiated 2004)
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Fig. 1 Distribution of EU projects across performance domains; classified by population groups and care settings and disease fields
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additionally combined different kinds of methods (e.g.
EuroHOPE, which combines administrative and survey
data, e.g. to assess patient satisfaction, or DuQue, which
combines patient outcome data and surveys). It can also
be observed that projects addressing CVD, those with
no clear disease focus as well as those addressing various
diseases were quite wide-spread in their methodology
and made use of almost all research instrument, whereas
most of the cancer-only projects used registries (Fig. 2).
Figure 2 furthermore indicates follow-up projects in
our sample (marked with “*”) which use existing data-
bases for further investigations (e.g. EURHOBOP, which
followed EUPHORIC, or ECHIM, which followed ECHI
and ECHI II). We also marked collaborative research
networks between projects (“**”), thus EUNICE, which
operates a network with primary care data providers,
collaborates with EuroCARE about their survival registry
data and with EUROCHIP about their cancer health
indicators. Another example in the field of cancer is
RARECARE, a project that helps define indicators and
collects data on rare cancers and which collaborates
with EUROCARE about their survival registry data, with
HAEMACARE on bridging the gap between clinical re-
search and public health information systems, and with
EUROCHIP on their indicators.
The following example is to demonstrate the good use
of such collection of projects. Using the example of CVD,
our hypothetical researcher would theoretically be enabled
to compare, for example, risk factors, development of the
disease, as well as monitoring and treatment by triangulat-
ing research results from EPIC-CVD, Monica, EROS,
EUROCISS, EurHOBOP, OECD Study, EuroHOPE and
EuroDRG. This kind of performance comparison is, how-
ever, still enormously hampered by poor linkage possibil-
ities of data from different providers and sectors (e.g.
hospitals, ambulatory care, pharmaceuticals) in many
countries as, especially in the field of individual-level
health data, many restrictions exist (e.g. in Germany) [9].
Discussion
The study was driven by the idea to provide a potential
user of comparative healthcare information with an
Fig. 2 Overview of project objectives and methods
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inventory of relevant health data across the EU accord-
ing to their research need (see our inclusion criteria).
The first research question, however, already revealed
that it is often not easy to find adequate project informa-
tion. Both of the used information systems did not
prove to be entirely sufficient in providing information
needed to obtain a proper understanding of the pro-
jects’ contents. Deliverables, such as intermediate results,
were often not presented or initial project descriptions not
updated, even upon project completion. On CORDIS, the
quality of information varied considerably between pro-
jects; in some cases, projects were presented in detail and
also publications listed, in other cases it was not even pos-
sible to find a project website or names of project coordi-
nators. Even though FP7 has addressed many of the
criticisms of its predecessors [3], comparing our observa-
tions to those done in 2009 for FP5 and 6, not much
seems to have changed with regard to CORDIS and its dif-
ficulties to obtain data.
Once we tried to access individual project websites,
the same was often experienced, with user unfriendly,
not updated, non-existent or incomplete project websites
lacking basic information on project background, method-
ology and results. An overview of the number of publica-
tions listed on each website can be found in Additional
file 2. The results reveal large differences between projects
and associated publications. In order to obtain a realistic
idea about the extent of research funding that is not
reflected by the number of publications, a next step
should focus on relevant literature databases. Thus,
project consortiums should provide complete and easily
accessible project websites hosting all relevant informa-
tion regarding the background, methodology (including
sample, data collection process, etc.) and results of the
projects (final report, individual outcomes, indicator
list) on completion of the study and updates on the
progress (e.g. interim reports) when the study is still
ongoing. It would be more than unfortunate if good
project results disappeared due to poor communication
management or because websites were seen as internal
communication tools only. Especially funders or govern-
ments of under-represented areas might thus be able to
spot gaps in existing data, find information on what data
have already been processed by others and even use it as a
basis or prototype for (local) application and simultan-
eously be encouraged to collect data in under-represented
areas [8]. Ideally, websites would also host the project da-
tabases, accessible for researchers or policymakers (e.g.
EUROCISS, SHARE) or, as suggested by Galsworthy et al.
[10], to have databases generated by projects to be shared
mandatorily as project deliverables via central searchable
EU repositories. Further, open access to databases at some
point after project completion should be allowed for
meta-analyses, for example. Initiatives such as the Open
Science Prize (https://www.openscienceprize.org/) in
the field of biomedical research encourage open con-
tent solutions to improve health, which are worth con-
sidering in other fields.
In the next step, all projects were carefully analysed to
learn about specific research aims and methods used,
collaborations developed, and information produced.
Overall, we saw that only a few projects had produced the
type of data required for proper performance assessment,
i.e. that collect not only individual-level data on healthcare
performance but also on non-healthcare determinants of
health, which impedes proper risk-adjustment. On the
other hand, population-based projects, which include such
data, almost always lack information on healthcare, i.e. do
not allow a performance assessment. This supports previ-
ous research indicating that societal needs are not
reflected by investments in many funding schemes [11],
such as two United Kingdom studies [12, 13] that com-
pared levels of research funding with measures of the bur-
den of disease in the field of infectious diseases as well as
in cancer, coronary heart disease, dementia and stroke,
and found that funding overall increased within the last
years, however, not in relation to their burden of disease.
Nevertheless, Horizon 2020 is supposed to address major
societal issues such as health and sustainability by, for
example, introducing a detailed online hierarchical
categorisation of EU investments – similar to the US
National Institutes of Health’s RePORTER website –
allowing national funders to see collaboration oppor-
tunities and gaps [7].
Furthermore, based on our findings, projects should
include healthcare utilisation and cost information, which
would allow an assessment of the quality of care at differ-
ent levels (e.g. hospitals, regions, countries). More mixed-
method designs would also be useful, for example, cancer
projects could incorporate patient discharge data com-
bined with surveys. Additionally, patient-based projects
would not only benefit from including non-healthcare
determinants, but also from linking their results to cost
information (such as EuroHOPE or ECHO) and patient
experiences. Other challenges hampering international
comparisons are due to a lack of available or accessible
data in certain countries and areas, or differences in
data collection among countries, e.g. regarding effective
care pathways, disparities in healthcare utilisation, pa-
tient experience, costs and expenditure, and/or even
the most basic descriptive data on socioeconomic in-
equalities. These observations are partly supported by
previous research reporting on research priorities across
most fields of public health in European countries [14].
Another issue we came across was the problem of sustain-
ability due to the time-limited construction of the projects
and associated funding. Once the projects ended, often,
no project website was updated and there was no
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continued effort to keep the database alive. However,
databases generated by projects need to be sustained
after completion of projects. In 2015, the BRIDGE
Health Project (BRidging Information and Data Gener-
ation for Evidence-based Health policy and research;
www.bridge-health.eu) was launched to develop a sustain-
able and integrated EU health information system for both
health and research purposes. One of the aims is to con-
tinue the work of selected projects relevant for performance
assessment, such as ECHO and EuroHOPE.
Limitations
The aim of this paper was to analyse whether there
would be enough research output of EU projects avail-
able to conduct proper health system performance. Our
approach was to create an option to understand and cat-
egorise the output of EU projects by demonstrating a
potential solution to systematically analyse them. Since
this aim was very ambitious, several limitations were en-
countered. Inclusion criteria for projects were applied
and the search was limited to specific databases only.
Thus, relevant projects for health system performance
beyond our inclusion criteria and those that were not
EU-funded were not considered for the analysis. Further-
more, in CORDIS, only keywords for diseases were used
as indicated in the text. Thus, we assumed that, by enter-
ing e.g. ‘chronic obstructive pulmonary disease’ instead of
COPD, no loss of study information would be implied.
Another limitation refers to the approach of assessing per-
formance using projects that were not explicitly funded
for performance evaluation. However, we assumed that
the overall goal of health-related research should be to im-
prove performance of health systems.
Conclusions
This study has indicated that public money spent on
health research projects and initiatives has produced a
huge amount of useful output. At the same time, however,
individual projects do not deliver the breadth of informa-
tion that is necessary for proper health system performance
assessment and international comparisons. Therefore, our
findings suggest to strengthen the effort of developing
datasets that harmonise data from national health surveys
and national mortality registries, for example, to allow
international comparisons (e.g. EUROTHINE, ONCO-
POOL), as well as to implement European-wide bench-
marking on outcomes, quality and costs enabling decision-
makers as well as health professionals at different levels to
learn from the best practices. Additionally, the findings
strongly recommend that funders should take clear re-
sponsibility not only to make research papers and reports
adequately available, but also to ensure that results are
made known to the research community, policymakers
and funders. CORDIS, as a research and development in-
formation service, needs to strengthen its effort to ensure
that relevant and detailed project information is adequately
shared.
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